Lennox International Stock News

Lennox (LII) delivered earnings and revenue surprises of 16.26% and 4.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Lennox (LII) delivered earnings and revenue surprises of 16.26% and 4.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Lennox (LII) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Lennox (LII) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Within the last quarter, Lennox International (NYSE:LII) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 1 0 La

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

Lennox International Inc. (NYSE: LII) has appointed Alok Maskara as its CEO, effective on May 9, 2022. Maskara succeeds Todd Bluedorn, who announced in July 2021 his plans to step down by mid-2022

Higher pricing and operating leverage, given prudent investments in technology, are likely to have aided Lennar's (LEN) fiscal Q1 performance.

Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter

Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ: RVMD ) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $50.88 and a 52-week-low of $18.07. At the end of the last trading period, Revolution Medicines closed at $18.92. According to UBS, the prior rating for Amedisys Inc (NASDAQ: AMED ) was changed from Sell to Neutral. For the fourth quarter, Amedisys had an EPS of $1.18, compared to year-ago quarter EPS of $1.49. At the moment, the stock has a 52-week-high of $292.97 and a 52-week-low of $122.12. Amedisys closed at $160.24 at the end of the last trading period. For Sunstone Hotel Investors Inc (NYSE: SHO ), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. At the moment, the stock has a 52-week-high of $13.91 and a 52-week-low of $9.93. Sunstone Hotel Invts closed at $10.58 at the end of the last trading period. Wedbush upgraded the previous rating for Logitech International SA (NASDAQ: LOGI ) from Neutral to Outperform.

Secrets from the iconic Baywatch swimsuit, prosthetic-proof swimsuits, and more.

DALLAS, Feb. 21, 2022 /PRNewswire/ -- Lennox International Inc. (NYSE: LII), a global leader in energy-efficient climate control solutions, today announced that CFO Joe Reitmeier is scheduled to pres

Lennox International Inc (LII) shares closed 0.2% lower than its previous 52 week low, giving the company a market cap of $9B. The stock is currently down 22.1% year-to-date, down 13.0% over the past 12 months, and up 64.8% over the past five years. This week, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 2.7%. Trading Activity Trading volume this week was 41.4% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 78.6% The company's stock price performance over the past 12 months lags the peer average by -123.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -59.0% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Related Stocks: VWO , FALN , VWOB , VGIT , VGLT , IEMG , LII , EFAV , EEMV , IWS , EFG , FNDA , BSV , PHYS , XLF , REGN , GDX , VIG ,